Articles

Results 1 to 5 of 10
Most popular |Most recent


Federal Court of Appeal defers to Health Canada on interpretation of

Canada - April 20 2021 In its first decision addressing and interpreting the scope of the Certificate of Supplementary Protection Regulations, the Federal Court of Appeal…

Adam Heckman, John Norman PhD.

Takeda successfully defends Canadian VYVANSE® patent on appeal

Canada - March 12 2021 The Federal Court of Appeal has dismissed two appeals[1] brought by Apotex in respect of the validity of certain claims of Takeda’s (as Shire)…

Frédéric Lussier.

Amendments to the Patented Medicines Regulations delayed by

Canada - December 31 2020 The coming-into-force date of the Regulations Amending the Patented Medicines Regulations ("the Amendments") has been delayed by 6 months until July 1…

Alex Gloor, John Norman PhD.

Strike 2: Health Canada's narrow interpretation of the CSP Regulations rejected once again

Canada - July 22 2020 In April, the Federal Court issued its first decision interpreting the Certificate of Supplementary Protection Regulations (the "CSP Regulations") in…

Alexander Camenzind, Cole Meagher.

COVID-19 Emergency Response Act: Amendments to the Patent Act

Canada - March 26 2020 After lengthy deliberations, the Federal Government has passed an aid bill in response to the COVID-19 pandemic (COVID-19 Emergency Response Act). The…

Jay Zakaïb, Jennifer L. Wilkie, Marc Richard.